CEA [CHINA EASTERN AIRLINES] 6-K: China Eastern Airlines Corporation Limited Date April 15,
[China Eastern Airlines Corporation Limited Date April 15, 2019 By Wang Jian Company Secretary]
[China Eastern Airlines Corporation Limited Date April 15, 2019 By Wang Jian Company Secretary]
[Number 1.1 Notice of the Annual General Meeting, dated April 12, 2019 2.1 Circular, dated April 12, 2019 • our business objectives and strategies, including those relating to the development of our terminal procurement and distribution business; • our operations and prospects; • our network expansio]
[PETROCHINA COMPANY LIMITED (a joint stock limited company incorporated in the Peoples Republic of China with limited liability) (Stock Code: 857) Resignation of Director Board Company The board of directors (the Mr. Qin Weizhong has confirmed that he has no disagreement with the Company and the B]
[China Jo-Jo Drugstores Announces the Closing of $10 Million Registered Direct Offering The Company received net proceeds from the offering in the amount of approximately $9.3 million, after deducting the placement agent fees and the estimated offering expenses payable by the Company. H.C. Wainwright]
[Number 1.1 Notice of the Annual General Meeting, dated April 12, 2019 2.1 Circular, dated April 12, 2019 • our business objectives and strategies, including those relating to the development of our terminal procurement and distribution business; • our operations and prospects; • our network expansio]
[PETROCHINA COMPANY LIMITED (a joint stock limited company incorporated in the Peoples Republic of China with limited liability) (Stock Code: 857) Resignation of Director Board Company The board of directors (the Mr. Qin Weizhong has confirmed that he has no disagreement with the Company and the B]
[China Jo-Jo Drugstores Announces the Closing of $10 Million Registered Direct Offering The Company received net proceeds from the offering in the amount of approximately $9.3 million, after deducting the placement agent fees and the estimated offering expenses payable by the Company. H.C. Wainwright]
[Sinovac Update on the Exchange of Rights for Common and Series B Preferred Shares April 12, 2019 05:04 PM Eastern Daylight Time BEIJING--(BUSINESS WIRE)--Sinovac Biotech Ltd. (NASDAQ:SVA) (“Sinovac” or the “Company”), a leading provider of biopharmaceutical products in China, today provided an updat]
[FORM 20-F (Mark One) o OR x For the fiscal year ended December 31, 2018. OR o For the transition period from to OR o Date of event requiring this shell company report . . . . . . . . . . . . . . . . . . . JD.com, Inc. N/A Cayman Islands (Jurisdiction of Incorporation] [EXCLUSIVE TECHNOLOGY CONSULTIN]
[Sinovac Update on the Exchange of Rights for Common and Series B Preferred Shares April 12, 2019 05:04 PM Eastern Daylight Time BEIJING--(BUSINESS WIRE)--Sinovac Biotech Ltd. (NASDAQ:SVA) (“Sinovac” or the “Company”), a leading provider of biopharmaceutical products in China, today provided an updat]